As you probably know by now – May is National Cancer Research Month, and this is the second post in our blog series to profile cancer research programs underway at Sanford-Burnham. This week, we review a few of the programs that focus on a malfunctioning signaling process in cells called “signal transduction.” Signal transduction occurs when a molecule outside of a cell activates a receptor on the cell, triggering a response inside. This vital process drives a variety of functions, including how a cell senses and responds to environmental change and communicates with other cells. When signal transduction pathways malfunction, a variety of diseases can arise, including cancer.
Sanford-Burnham researchers identified a potential drug target to prevent the hardening of arteries...


















